Meet Paul Edalat, the CEO and founder of Vivera Pharmaceutical, an innovative science-driven pharmaceutical company in Southern California. Vivera’s core verticals include medical devices, advanced diagnostics, medical technologies, medical supplies, neurosciences, and biosciences divisions, each working synergistically to support Vivera’s core mission of putting patients first.
Paul started his career in the fitness and nutrition industry, working in various roles that gave him a deep understanding of business. He was fortunate to have the opportunity to work alongside some incredibly talented and dedicated professionals, which helped Paul shape his perspective and approach to leadership.
However, in 2004, Paul’s brother Peter was diagnosed with an aggressive form of Hodgkin’s lymphoma. During Peter’s battle with cancer, Paul witnessed the flaws of our healthcare system and realized the need for a pharmaceutical company that genuinely cares for patients, which eventually led to the inception of Vivera Pharmaceutical in 2018.
Establishing Vivera
While Paul’s brother battled cancer, Paul discovered a significant issue in the healthcare industry regarding the prescribing and administering of medications. Peter’s doctor prescribed him high doses of opioids to manage his chemotherapy-induced pain. However, Peter exceeded the recommended dosage without proper safety protocols and developed an addiction. It was heartbreaking to witness him struggling with both cancer and addiction. This experience led Paul to recognize the need for a more effective approach to prescribing and dispensing medications, which motivated him to establish Vivera. Together with Dr. Mehdi Hatamian, one of the most brilliant individuals Paul knows, they developed ZICOH, a patented smart drug delivery system for prescription medications.
Simplifying the Drug Delivery Process
Under Paul’s leadership, Vivera Pharmaceuticals acknowledges the intricacies of the healthcare industry and understands that the drug delivery process needs to be simplified and made more efficient for all involved, including patients, healthcare providers, pharmacists, and other stakeholders in the drug supply chain. To achieve this objective, Vivera Pharmaceuticals has introduced ZICOH, a patented drug delivery solution that partners with ZICOH ConnectTM, a cloud-based software system that synchronizes and aggregates prescribing and dispensing data. The combination of these two technologies generates valuable insights for healthcare providers aimed at enhancing patient adherence and prescribing oversight for addictive and controlled medications. Vivera Pharmaceuticals’ primary goal with ZICOH is to ensure that drug delivery is safer, faster, and more efficient for all stakeholders in the healthcare industry.
Fostering Creativity and Innovation
Paul believes it is vital to promote creativity and innovation while maintaining a healthy work environment to ensure any organization’s long-term success. One way to encourage such creativity is by bringing together team members from diverse backgrounds and departments. This creates an opportunity for unique perspectives and creative problem-solving that can propel the organization forward. By fostering a collaborative work environment, companies can ensure team members feel valued and encouraged to contribute their ideas. Ultimately, this approach can lead to greater success and help organizations stay competitive in a rapidly evolving business landscape.
“Leading a company in a rapidly evolving environment can be challenging, so it’s essential to be adaptable. Change is constant, so I consciously try to remain open to new ideas and agile in my decision-making processes,”- states Paul. “Having a vision and purpose is also crucial to good leadership. At Vivera, our vision is to improve patients’ lives.”
When Data is Crucial
Paul believes although data plays a crucial role in the pharmaceutical industry, its full potential is yet to be realized. Pharmaceutical companies can uncover previously unknown patterns and relationships through advanced analytics, AI, and machine learning, leading to more efficient drug discovery, better decision-making, and improved patient outcomes.
Vivera Pharmaceuticals has long recognized the value of data in the healthcare industry. The ZICOH solution utilizes AI to organize vast, complex, unstructured prescribing data to generate predictive analytics. As a healthcare and drug delivery leader, Paul has emphasized the importance of leveraging AI to remain competitive and achieve success. Companies that harness the full potential of AI will be well-positioned to succeed in the rapidly evolving healthcare landscape.
Looking at the Future
Paul’s primary objective is to improve medication adherence and safety for patients. By focusing on drug delivery, Vivera aims to enhance patient experiences and potentially improve outcomes. Paul’s ultimate goal is to collaborate with healthcare providers to ensure every patient can access TABMELT and ZICOH. Having seen the difficulties that patients face in taking medications, particularly when sick, and the risk of becoming dependent on addictive prescriptions, Paul is committed to making a difference. Addiction can have severe consequences not just for the patients but also for their families, friends, and communities. With ZICOH, Paul and his team at Vivera are working to prevent addictive drugs from ending up in the wrong hands and ensure that patients are not exposed to addiction when they are most vulnerable.
Discussion about this post